Acutus Medical, Inc.

FY: Dec 31 2024

Q: Sep 30 2024

Q: Jun 30 2024

Q: Mar 31 2024

FY: Dec 31 2023

Q: Sep 30 2023

Q: Jun 30 2023

Q: Mar 31 2023

FY: Dec 31 2022

Q: Sep 30 2022

Q: Jun 30 2022

Q: Mar 31 2022

FY: Dec 31 2021

Q: Sep 30 2021

Q: Jun 30 2021

Q: Mar 31 2021

FY: Dec 31 2020

Q: Sep 30 2020

Q: Jun 30 2020

Results of Operations and Financial Condition

Entry into a Material Definitive Agreement

Cost Associated with Exit or Disposal Activities

Entry into a Material Definitive Agreement

2.02,9.01

Entry into a Material Definitive Agreement

2.02

5.07,9.01

3.01

2.02

3.01

2.02

1.01,2.04,3.03,9.01

1.02

5.02

5.02,9.01

1.01,2.03,9.01

2.02,2.05,2.06,5.02,7.01,9.01

3.01

2.02,9.01

No description available

Notice of Effectiveness

Notice of Effectiveness

Post Effective Amendment to S-8

Post Effective Amendment to S-8

Post Effective Amendment to S-8

Post Effective Amendment to S-8

Post Effective Amendment to S-8

Post-effective amendment to a registration statement

Post-effective amendment to a registration statement

Notification of removal from listing and/or registration on a national securities exchange

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Notice of Effectiveness

Prospectus Supplement for Primary Offering

Registration statement under Securities Act of 1933

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Registration statement under Securities Act of 1933

06b

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Advent Life Sciences LLP

Flynn James E

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Flynn James E

Flynn James E

Flynn James E

LYTTON LAURENCE W

none

none

Mukai Takeo

Sohn Tom

Mukai Takeo

Sohn Tom

Mathews Kevin

Roman David

none

Mukai Takeo

Mathews Kevin

Sohn Tom

Roman David

Sohn Tom

Annual Report Scanned (Paper)

Specialized Disclosure Report

Annual Report Scanned (Paper)

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Draft registration statement (confidential submission)

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Draft registration statement (confidential submission) (amendment)

No description available

Letter from the SEC

Draft registration statement (confidential submission)